<bill session="117" type="s" number="4638" updated="2022-12-29T18:48:38Z">
  <state datetime="2022-07-27">REFERRED</state>
  <status>
    <introduced datetime="2022-07-27"/>
  </status>
  <introduced datetime="2022-07-27"/>
  <titles>
    <title type="display">Allowing Greater Access to Safe and Effective Contraception Act</title>
    <title type="short" as="introduced">Allowing Greater Access to Safe and Effective Contraception Act</title>
    <title type="official" as="introduced">A bill to allow women greater access to safe and effective oral contraceptive drugs intended for routine use.</title>
  </titles>
  <sponsor bioguide_id="E000295"/>
  <cosponsors>
    <cosponsor bioguide_id="G000386" joined="2022-07-27"/>
  </cosponsors>
  <actions>
    <action datetime="2022-07-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-07-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="8428" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-11-21T16:20:52Z" status="Introduced in Senate">Allowing Greater Access to Safe and Effective Contraception Act

This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter oral contraceptives that are intended for routine use.</summary>
</bill>
